Showing results (1-10 of 101) with videos related to
Sort By:
Pageof 11
Leukemia & Lymphoma|January 1, 1993
What is the best treatment for acute promyelocytic leukemia?G Avvisati, M C Petti, F MandelliHaematologica|December 29, 1998
Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approachF Mandelli, M C Petti, F Lo CocoBiomedicine / [Publiee Pour L'A.A.I.C.I.G.]|January 1, 1980
Cytokinetic studies in chronic lymphocytic leukemia. Relationship to other variables at diagnosis and survivalM C Petti, M G Testa, G Deb, et al.Acta Haematologica|January 1, 1979
Drug-induced kinetic perturbations of the marrow blasts in acute leukemia. Effects of the daunorubicin, cytosine arabinoside and 6-thioguanine combinationS Amadori, M C Petti, C Mastrovincenzo, et al.Blood|June 15, 1990
BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remissionG Meloni, P De Fabritiis, M C Petti, et al.Infection|May 1, 1985
Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignanciesP Martino, M Venditti, M C Petti, et al.Tumori|May 1, 1981
Therapy of acute nonlymphocytic leukemia in children: a review of 73 patientsS Amadori, M C Petti, L Pacilli, et al.The American Journal of the Medical Sciences|May 1, 1984
Cotrimoxazole prophylaxis in patients with leukemia and prolonged granulocytopeniaP Martino, M Venditti, M C Petti, et al.Haematologica|January 1, 1990
Defective antibody-dependent and lectin-induced polymorphonuclear cytotoxicity in patients with myelodysplastic syndromesL Fontana, G De Sanctis, V Bottari, et al.Leukemia|February 1, 1989
Phase II trial of intermediate dose ARA-C (IDAC) with sequential mitoxantrone (MITOX) in acute myelogenous leukemiaS Amadori, G Meloni, M C Petti, et al.Pageof 11